Reshape Lifesciences Inc Asset Turnover Ratio (RSLS), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Reshape Lifesciences Inc  (NASDAQ: RSLS)
 

Reshape Lifesciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2026, Reshape Lifesciences Inc's asset turnover ratio sequentially decreased to 0.3 in the first quarter (Mar 31 2026), this is lower than usual.

Within sector 112 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 1953 to 2204.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RSLS Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change 112.51 % 25.47 % 41.22 % -21.24 % -55.05 %
Y / Y Revenue Change -96.31 % -98.49 % -36.79 % -42.75 % -55.23 %
Asset Turnover Ratio (TTM) 0.3 0.47 0.85 1.07 1.13
RSLS's Total Ranking # 2204 # 1953 # 2322 # 2318 #
Seq. Asset Change 44.57 % -21.96 % 39.26 % 35.26 % -14.64 %
Seq. Revenue Change -8.77 % -97.21 % 11.59 % 30.02 % -62.65 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 113
Healthcare Sector # 366
Overall Market # 2204

Asset Turnover Ratio Statistics
High Average Low
1.13 0.38 0.01
(Dec 31 2024)   (Dec 31 2018)




RSLS Company Profile • Back to RSLS Efficiency Comparisons • Compare RSLS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Allurion Technologies Inc   0.65 $ 12.357  Millions$ 19.019  Millions
Eli Lilly And Company  0.65 $ 72,249.500  Millions$ 111,227.500  Millions
Tg Therapeutics Inc   0.65 $ 700.349  Millions$ 1,079.932  Millions
Immucell Corporation  0.65 $ 29.035  Millions$ 44.773  Millions
Staar Surgical Co  0.65 $ 290.375  Millions$ 449.235  Millions
Bioaffinity Technologies Inc   0.64 $ 5.660  Millions$ 8.801  Millions
Novocure Limited  0.64 $ 674.414  Millions$ 1,049.830  Millions
Akebia Therapeutics Inc   0.64 $ 232.404  Millions$ 362.208  Millions
Stereotaxis Inc   0.64 $ 30.801  Millions$ 48.260  Millions
Sarepta Therapeutics Inc   0.64 $ 2,184.184  Millions$ 3,425.472  Millions
Halozyme Therapeutics Inc   0.64 $ 1,508.458  Millions$ 2,368.293  Millions
Procept Biorobotics Corporation  0.64 $ 321.012  Millions$ 504.934  Millions
Ss Innovations International Inc  0.63 $ 48.259  Millions$ 76.082  Millions
Macrogenics Inc   0.63 $ 157.083  Millions$ 247.724  Millions
Zoetis Inc   0.63 $ 9,509.000  Millions$ 15,064.750  Millions
Twist Bioscience Corporation  0.63 $ 409.479  Millions$ 649.941  Millions
10x Genomics Inc   0.63 $ 637.614  Millions$ 1,016.114  Millions
Vericel Corporation  0.63 $ 292.086  Millions$ 465.619  Millions
Viskase Holdings inc   0.62 $ 87.424  Millions$ 140.040  Millions
Anika Therapeutics Inc   0.62 $ 116.123  Millions$ 186.694  Millions
Heartflow Inc   0.62 $ 189.487  Millions$ 306.810  Millions
Neuraxis Inc   0.61 $ 4.282  Millions$ 7.004  Millions
Heron Therapeutics Inc   0.61 $ 150.184  Millions$ 245.783  Millions
Castle Biosciences Inc   0.61 $ 339.920  Millions$ 558.469  Millions
Onemednet Corporation  0.61 $ 1.139  Millions$ 1.875  Millions
Capsovision Inc   0.60 $ 11.972  Millions$ 19.829  Millions
Vsee Health Inc   0.60 $ 11.786  Millions$ 19.587  Millions
Bionexus Gene Lab Corp   0.60 $ 5.311  Millions$ 8.834  Millions
Globus Medical Inc   0.60 $ 3,100.664  Millions$ 5,199.761  Millions
Cumberland Pharmaceuticals Inc   0.60 $ 41.940  Millions$ 70.406  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.